Outcomes in Education and Counseling for HNPCC Testing
loss of heterozygosity analysis
+ microsatellite instability analysis
+ mutation analysis
Colonic Diseases+10
+ Digestive System Diseases
+ Digestive System Neoplasms
Summary
Study start date: February 1, 2000
Actual date on which the first participant was enrolled.OBJECTIVES: Identify family characteristics, personality traits, and religious and spiritual beliefs that significantly affect individual decisions regarding mutation testing for hereditary nonpolyposis colon cancer (HNPCC) (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues). Determine the impact of negative vs positive mutation test results on family relationships and psychological status. Assess expectations regarding testing and how they influence perceptions of risks and responses to risk notification. Determine the impact of risk notification on the frequency of screening/prevention activities. Formulate a standard diagnostic algorithm for determining microsatellite instability based on the analysis of tumors with this extensive array of markers and correlate specific replication error phenotypes with germline genotype. OUTLINE: Participants complete a baseline assessment of knowledge, risk perception, and personality traits followed by a structured pretest education session. Participants are then offered the choice of whether or not to undergo genetic testing for mutations in hereditary nonpolyposis colon cancer (HNPCC) genes. Participants who choose to undergo genetic testing provide a blood sample for this purpose. Participants who undergo genetic testing receive results and counseling (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues). Available surveillance options are discussed for all participants. Psychological and behavioral outcomes are reassessed at 6 and 12 months for both those choosing and not choosing genetic testing. Tumors (when available) are analyzed for mismatched repair deficiency on the basis of microsatellite instability. PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study, with a specific target of 200 individuals who have not experienced cancer within families identified with hereditary nonpolyposis colon cancer (HNPCC) mutations (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.900 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
DISEASE CHARACTERISTICS: Meets one of the following criteria: Family history consistent with hereditary nonpolyposis colon cancer (HNPCC)* At least 3 relatives with histologically proven colorectal cancer or HNPCC-associated cancer and 1 is a first-degree relative of the other 2 At least 2 successive generations affected Colorectal cancer (or HNPCC-associated cancer) diagnosed under age 50 in 1 of the relatives Diagnosis of colorectal cancer under age 41 HNPCC-associated cancer/polyps* under age 41 with a microsatellite instability (MSI) phenotype Multiple primary HNPCC-associated cancers* regardless of family history Colorectal or other HNPCC-associated tumor/polyp* demonstrating a positive MSI phenotype and at least 1 second-degree (or closer) and 1 third-degree (or closer) relative with a HNPCC-associated cancer 1 affected family member must have one of the following: Right-sided colon cancer Multiple primary HNPCC-associated cancers Diagnosis of cancer prior to age 51 NOTE: *Recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine: Not specified Radiotherapy: Not specified Surgery: Not specified
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Bethesda, United StatesOpen Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office in Google MapsNational Human Genome Research Institute
Bethesda, United States